![Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases | Cardiovascular Diabetology | Full Text Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-022-01524-6/MediaObjects/12933_2022_1524_Fig4_HTML.png)
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases | Cardiovascular Diabetology | Full Text
![Understanding How Statins Prevent Cardiovascular Disease but Increase Diabetes Risk | Stanford Cardiovascular Institute | Stanford Medicine Understanding How Statins Prevent Cardiovascular Disease but Increase Diabetes Risk | Stanford Cardiovascular Institute | Stanford Medicine](http://med.stanford.edu/content/dam/sm/cvi/images/graphics/knowles-graphic.jpg)
Understanding How Statins Prevent Cardiovascular Disease but Increase Diabetes Risk | Stanford Cardiovascular Institute | Stanford Medicine
![Associations of statin use with glycaemic traits and incident type 2 diabetes - Ahmadizar - 2019 - British Journal of Clinical Pharmacology - Wiley Online Library Associations of statin use with glycaemic traits and incident type 2 diabetes - Ahmadizar - 2019 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/4ab9c6ee-b269-4d40-8e13-560ceb473365/bcp13898-fig-0001-m.jpg)
Associations of statin use with glycaemic traits and incident type 2 diabetes - Ahmadizar - 2019 - British Journal of Clinical Pharmacology - Wiley Online Library
![Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet](https://www.thelancet.com/cms/attachment/2001010417/2003789589/gr1.gif)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet
![Insights Into Statin-Associated Diabetes: How Important is the Risk and How Should You Counsel Your Patient? - American College of Cardiology Insights Into Statin-Associated Diabetes: How Important is the Risk and How Should You Counsel Your Patient? - American College of Cardiology](https://www.acc.org/-/media/Clinical/Images/Approved-Images/2015/01/06/10/02/Cardiometabolic-Hot-Topic-table-1.png?la=en&hash=D488C05272593B4133950F720A744543A1B96C0D)
Insights Into Statin-Associated Diabetes: How Important is the Risk and How Should You Counsel Your Patient? - American College of Cardiology
![Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases | Cardiovascular Diabetology | Full Text Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-022-01524-6/MediaObjects/12933_2022_1524_Fig6_HTML.png)
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases | Cardiovascular Diabetology | Full Text
![Biomedicines | Free Full-Text | Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study Biomedicines | Free Full-Text | Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study](https://pub.mdpi-res.com/biomedicines/biomedicines-08-00499/article_deploy/html/images/biomedicines-08-00499-ag.png?1605260704)
Biomedicines | Free Full-Text | Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study
![Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy? | SpringerLink Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy? | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40256-013-0053-0/MediaObjects/40256_2013_53_Fig2_HTML.gif)
Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy? | SpringerLink
![Statins may increase diabetes, but benefit still outweighs risk | Cleveland Clinic Journal of Medicine Statins may increase diabetes, but benefit still outweighs risk | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/90/1/53/F3.large.jpg)
Statins may increase diabetes, but benefit still outweighs risk | Cleveland Clinic Journal of Medicine
![Statin-Related New-Onset Diabetes Appears Driven by Increased Insulin Resistance: Are There Clinical Implications? | Arteriosclerosis, Thrombosis, and Vascular Biology Statin-Related New-Onset Diabetes Appears Driven by Increased Insulin Resistance: Are There Clinical Implications? | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/7e031595-0e91-4054-a3ed-8b8249694ef6/atvbaha.121.316893.fig01.jpg)
Statin-Related New-Onset Diabetes Appears Driven by Increased Insulin Resistance: Are There Clinical Implications? | Arteriosclerosis, Thrombosis, and Vascular Biology
![IJMS | Free Full-Text | Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights IJMS | Free Full-Text | Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights](https://www.mdpi.com/ijms/ijms-21-04725/article_deploy/html/images/ijms-21-04725-g002.png)
IJMS | Free Full-Text | Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights
![Statin use and risk of developing diabetes: results from the Diabetes Prevention Program | BMJ Open Diabetes Research & Care Statin use and risk of developing diabetes: results from the Diabetes Prevention Program | BMJ Open Diabetes Research & Care](https://drc.bmj.com/content/bmjdrc/5/1/e000438/F2.large.jpg)
Statin use and risk of developing diabetes: results from the Diabetes Prevention Program | BMJ Open Diabetes Research & Care
![Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study | Cardiovascular Diabetology Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study | Cardiovascular Diabetology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-022-01466-z/MediaObjects/12933_2022_1466_Fig2_HTML.png)
Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study | Cardiovascular Diabetology
![Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial - The Lancet Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial - The Lancet](https://www.thelancet.com/cms/attachment/3d44e7be-3dad-471a-ab63-c66c4fed3c5d/gr1.jpg)